MANU AO SEMINAR TOBACCO CONTROL FOR MĀORI TE TOHU ME TE TAURANGI - GEORGE LAKING MD PHD FRACP MEDICAL ONCOLOGIST AUCKLAND DHB; - MASSEY UNIVERSITY
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
MANU AO Seminar Tobacco Control for Māori Te Tohu Me Te Taurangi George Laking MD PhD FRACP Medical Oncologist Auckland DHB; Trustee, Te Hotu Manawa Māori; Treasurer, Te ORA 06 Whiringa-a-Nuku 2010
UK Universities Superannuation Scheme 1 HSBC BANK 545.5 2 ROYAL DUTCH SHELL 501.2 3 VODAFONE GROUP 392.7 4 BP 340.3 5 GLAXOSMITHKLINE 312.4 6 BHP BILLITON 258.5 7 RIO TINTO 252 8 ASTRAZENECA 222.7 9 BRITISH AMERICAN TOBACCO 200.3 10 BG GROUP 184.3 11 TESCO 173.1 12 BARCLAYS 170.3 13 ANGLO AMERICAN 168.8 14 STD CHARTERED 162.2 15 UNILEVER (UK) 141.8 16 LLOYDS BANKING GROUP 140.2 17 DIAGEO 132.3 18 IMPERIAL TOBACCO 129.2 19 RECKITT BENCKISER 118.2 20 NESTLE R 108.9
New Zealand Tobacco Action Network (NZTAN) The online tobacco control community in NZ Administered by ASH, www.ash.org.nz Membership ~ 250 Used daily by the tobacco control community Academics / NGOs / Providers / Te Hotu Manawa Māori Te ORA Māori Medical Practitioners' Association Department of Public Health, University of Otago, Wellington Centre for Tobacco Control Research, University of Auckland ASH / Smokefree Coalition / Roopu Me Mutu
Māori Smoking and Tobacco Use Median age of Māori smoking initiation = 11.7 Current smokers – 46% of all Māori, 21% of all non-Māori Wāhine Māori who smoke – 49% (highest prevalence of any group) – in 25-29 agegroup almost 4x greater than non-Māori Lung cancer deaths – 31% of cancer deaths in Māori, vs 17% in non-Māori Contributes to 7-8 year LE gap – 2.3x higher cardiovascular death rate – 2.6x higher respiratory death rate
Māori Smoking and Tobacco Use Parents who smoke – ~50% in Māori, ~20% in non-Māori Roll-your-own tobacco use – 73% of Māori smokers ↓ Daily smoking among Māori – 2002/03: 47%; 2006/07: 38% >11700 Māori Registered with a quit service – e.g. Quit Group’s Quitline, web service and Txt2Quit . – after accessing Quitline services, 18% Māori quit Annual Māori tobacco excess mortality ~650
If nobody smokes tobacco from 2020 onwards, we estimate additional gains in life expectancy for Māori ranging from 2.5 to 7.9 years (average 4.7) and for non-Māori ranging from 1.2 to 5.4 years (average 2.9). Going smokefree as a nation by 2020, compared to no change from the 2006 Census population smoking prevalence, will close ethnic inequalities in life expectancy by 0.3 to 4.6 years (average 1.8 years; consistently greater for females). NZMJ 13 August 2010, Vol 123 No 1320
Interpretation of the Evidence. The association of lung cancer with cigarette smoking is generally agreed to be true but various possible explanations of this association other than that of cause and effect have to be considered. These are (para. 32) :– (i) that people who are going to get lung cancer have an increased desire to smoke throughout their adult lives: (ii) that smoking produces cancer only in the lungs of people who are in any case going to get cancer somewhere in the body, so that smoking determines only the site of the cancer: (iii) that lung cancer affects people who would have died of tuberculosis in former times but have now survived with lungs susceptible to cancer: (iv) that smokers inherit their desire to smoke and with it inherit a susceptibility to some other undiscovered agent that causes lung cancer: (v) that smokers are by their nature more liable to many diseases, including lung cancer, than the “self-protective” minority of non-smokers: (vi) that smokers tend to drink more alcohol than non-smokers so that drinking and not smoking may cause lung cancer: (vii) that motor car exhausts, or – (viii) that generalised air pollution may render the lungs of smokers more liable to cancer. None of these explanations fits all the facts as well as the obvious one that smoking is a cause of lung cancer.
“We cannot hope to win in a head-on confrontation. Our tactics must be to discover our opponents weaknesses, attack those particular points, cause as much confusion as possible, and attack somewhere else while their attention is distracted.” Philip Morris, 1978
Traditionally, epidemiology has been used to identify associations that point to possible causes of a disease, providing direction for thorough laboratory investigations. With smoking, the many laboratory investigations over the years have proved more problematic, and science has not to date been able to identify biological mechanisms which can explain with certainty the statistical findings linking smoking and certain diseases, nor has science to date been able to clarify the role of particular smoke constituents in these disease processes. www.batnz.com
Hanahan & Weinberg, The Hallmarks of Cancer, Cell, 2000
TUPEKA Agent Structure Chemistry Cancer Polycyclic aromatics Alkylating agent p53 dna adducts anti- (benzopyrone) apoptosis (Denissenko, Science 1996) Acrolein Glutathione depletion, Favours proliferation (propenal) oxidative stress (Kehrer, Toxicol. Sci. 2000) Nitrosamines Alkylating agents DNA adducts, strand (Arimoto-Kobayashi, breaks, Mutat Res 2007) anti-apoptosis
TUPEKA Agent Structure Chemistry Cancer Arsenic Thiol-affinity of Mutagenicity, As(III) oxides; proliferation oxidative stress (Kitchin, Chem Res Toxicol 2010) Nicotine Nicotinic AchR; Growth, Nitrosation (Sleiman, Anti-apoptosis Proc Natl Acad Sci USA (Lee, JNCI 2010) 2010) Smoke (n.o.s.) Plasminogen Addiction, Growth, activator Metastasis, (Du, Cancer Res 2007; Nagai, J Pharm Sci 2008)
“Of all the concerns, there is one – taxation – that alarms us the most.” Philip Morris, 1985
D O'Dea and G Thompson
Estimated prevalence elasticity for smoking of –0.20: so 20% price rise causes 4% relative fall in prevalence, e.g. absolute fall from 50% to 48% Million cigarette consumption in 4th quarter of FY 2008: 757 2009: 405.5
Ngā Mahi Kaupapa Māori Manaakitanga Whānaungatanga Rangatiratanga Kotahitanga Kaitiakitanga Maramatanga Wairuatanga
To increase the number of Māori smokers who make evidence based, supported quit smoking attempts, by doubling the number of Māori who have access to nicotine replacement therapy and support, immediately and at no cost; In the home / In the workplace / In schools. Awhi Mai Awhi Atu Aukati Kaipaipa Taonga puoro (porotiti)
National Māori Tobacco Control Service Steering Group – stakeholder networks Tobacco sector scoping exercise Communications plan Strategic plan to align with – Māori Affairs Select Committee recommendations – Whānau Ora processes.
georgel@adhb.govt.nz
You can also read